CCP
MDCO

Clough Capital Partners’s Medicines Co MDCO Stock Holding History

Clough Capital Partners’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-711,100
Closed -$15.9M – 222
2014
Q3 		$15.9M Sell
711,100
-101,100
-12% -$2.57M 0.59% 61
2014
Q2 		$23.6M Buy
+812,200
New +$21.7M 0.74% 50

Other funds holding MDCO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Clough Capital Partners's MDCO Position: Q4 2014 in Review

Clough Capital Partners sold out of Medicines Co (MDCO) in Q4 2014, closing a stake of 711,100 shares — an estimated $15.9M sold.

Clough Capital Partners first reported a position in MDCO in Q2 2014 and held it in 2 quarters. The position peaked at $23.6M in Q2 2014. 166 funds tracked by Wall St. Rank hold MDCO as of Q4 2014.

  • Clough Capital Partners reported no remaining Medicines Co position as of Q4 2014 after selling out during the quarter.
  • Clough Capital Partners sold 711,100 Medicines Co shares in Q4 2014, an estimated $15.9M.
  • Clough Capital Partners first reported a position in Medicines Co in Q2 2014 and held it in 2 quarters.
  • Clough Capital Partners's Medicines Co position peaked at $23.6M in Q2 2014.
  • 166 funds tracked by Wall St. Rank held Medicines Co as of Q4 2014.

Based on Clough Capital Partners's 13F filing for Q4 2014, filed 17 Feb 2015.